Mesalamine and Metoclopramide drug interactions - from FDA reports


Drug interactions are reported among people who take Mesalamine and Metoclopramide together. This study is created by eHealthMe based on reports of 45 people who take Mesalamine and Metoclopramide from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.


Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.



On Jan, 18, 2019

45 people who take Mesalamine, Metoclopramide are studied.


Number of reports submitted per year:

Mesalamine and Metoclopramide drug interactions.

Most common drug interactions over time *:

< 1 month:
  1. Back pain
  2. Ventricular fibrillation (abnormally irregular heart rhythm)
1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:
  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
2 - 5 years:
  1. Abdominal distension
  2. Abdominal pain
  3. Anaemia (lack of blood)
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Anxiety disorder
  6. Arthralgia (joint pain)
  7. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  8. Arthropathy
  9. Back pain
  10. Balance disorder
5 - 10 years:

n/a

10+ years:

n/a

not specified:
  1. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  2. Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
  3. Overdose
  4. Renal failure acute (rapid kidney dysfunction)
  5. Dehydration (dryness resulting from the removal of water)
  6. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  7. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  8. Diarrhoea
  9. Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
  10. Haemoglobin decreased

Most common drug interactions by gender *:

female:
  1. Abdominal pain
  2. Arthralgia (joint pain)
  3. Blood pressure decreased
  4. Constipation
  5. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  6. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  7. Erythema (redness of the skin)
  8. Fall
  9. Febrile neutropenia (fever with reduced white blood cells)
  10. Hospitalisation
male:
  1. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  2. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  3. Haemoglobin decreased
  4. Oxygen saturation decreased
  5. Diarrhoea
  6. Lethargy (tiredness)
  7. Blood alcohol increased
  8. Delusion (a false belief or opinion)
  9. Dysarthria (speech disorder)
  10. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)

Most common drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:
  1. Back pain
  2. Small intestinal obstruction (blockage in small intestine)
  3. Abdominal distension
  4. Abdominal pain
  5. Abdominal tenderness
  6. Abnormal behaviour
  7. Activities of daily living impaired
  8. Affective disorder (mental disorder)
  9. Alcoholism (problems with alcohol)
  10. Alopecia (absence of hair from areas of the body)
40-49:
  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Complications of transplanted liver
  3. Hepatic artery thrombosis (formation of a blood clot inside a hepatic artery)
  4. Liver abscess (pus in liver)
  5. Pulmonary embolism (blockage of the main artery of the lung)
  6. Abdominal pain
  7. Cellulitis (infection under the skin)
  8. Diarrhoea
  9. Gastroenteritis clostridial (inflammation of stomach and intestine clostridial)
  10. Hospitalisation
60+:
  1. Blood alcohol increased
  2. Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
  3. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  4. Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
  5. Overdose
  6. Pain in extremity
  7. Renal failure acute (rapid kidney dysfunction)
  8. Telangiectasia (small dilated blood vessels near the surface of the skin)
  9. Thrombocytopenia (decrease of platelets in blood)
  10. White blood cell count decreased

* Approximation only. Some reports may have incomplete information.

Do you take Mesalamine and Metoclopramide?


You are not alone:




Related studies

Mesalamine

Mesalamine has active ingredients of mesalamine. It is often used in ulcerative colitis. (latest outcomes from Mesalamine 7,033 users)

Metoclopramide

Metoclopramide has active ingredients of metoclopramide hydrochloride. It is often used in nausea. (latest outcomes from Metoclopramide 51,519 users)


Browse by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Mesalamine and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Metoclopramide and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Mesalamine and Metoclopramide
a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

What would happen?

Predict new side effects and undetected conditions when you take Mesalamine and Metoclopramide (13,249 reports studied)

FDA reports used in this study



Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!